Incidence and Predictors of Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve Replacement
Authors:
- 28 May 2015
- journal article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 38 (7) , 878-886
Abstract
Background: Transcatheter aortic valve replacement (TAVR) has emerged as an alternative treatment for patients with symptomatic aortic stenosis who are at high risk for surgical aortic valve replacement. The development of conduction abnormalities is a major complication in the postprocedural period of TAVR.Objectives: The objective of this study was to investigate the development of postprocedural conduction abnormalities and the requirement of permanent pacemaker (PPM) implantation in patients undergoing TAVR.Methods: Data from 137 consecutive patients who underwent TAVR (Edwards SAPIEN valve, Edwards Lifesciences, Irvine, CA, USA) between June 2008 and October 2012 were reviewed. Patients with prior history of PPM (n = 27) were excluded. The role of various predictors for pacemaker implantation after TAVR, including the valve index (calculated as [valve size/left ventricular outflow tract diameter] × 100) was investigated.Results: A total of 31/110 (28.2%) patients required implantation of a PPM after TAVR. The median time to implantation of a PPM was 5 days after the procedure. The development of postprocedural complete heart block was the most common indication for implantation of a PPM (16/31; 51.6%). On multivariate analysis, the presence of preexisting right bundle branch block (RBBB) was found to be a strong predictor of PPM implantation after TAVR (adjusted odds ratio: 4.87; 95% confidence interval: 1.29–18.46, P = 0.020). Using the receiver operated curve analysis, a cut‐off value of valve index of 128 was found to be a strong predictor for PPM implantation with a sensitivity of 73% and specificity of 61% (c statistic = 0.68).Conclusions: This study identified the presence of prior RBBB and a valve index of 128 as important risk factors for PPM implantation after TAVR. A larger implanted valve size relative to left ventricular outflow tract diameter leads to a greater compression of the intrinsic conduction system, increasing the need for pacemaker placement.Keywords
This publication has 36 references indexed in Scilit:
- Persistent Annual Permanent Pacemaker Implantation Rate After Surgical Aortic Valve Replacement in Patients With Severe Aortic StenosisThe Annals of Thoracic Surgery, 2012
- 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacementThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesisJournal of Interventional Cardiac Electrophysiology, 2011
- One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) RegistryCirculation, 2011
- Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk PatientsNew England Journal of Medicine, 2011
- Incidence, Predictors, and Outcome of Conduction Disorders After Transcatheter Self-Expandable Aortic Valve ImplantationThe American Journal of Cardiology, 2011
- Permanent pacemaker implantation after isolated aortic valve replacement: incidence, risk factors and surgical technical aspectsJournal of Cardiovascular Medicine, 2010
- Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesisAmerican Heart Journal, 2009
- Risk Factors for Requirement of Permanent Pacemaker Implantation After Aortic Valve ReplacementJournal of Cardiac Surgery, 2006
- Risk factors for pacemaker implantation following aortic valve replacement: a single centre experienceHeart, 2003